ISCO is in the news again. This time its the San Diego Union Tribune that is featuring ISCO's progress in its Parkinson's diease program and the collaboration with Duke University.
Read the whole feature here.
Monday, September 16, 2013
Thursday, September 5, 2013
Agora Financial Features ISCO in latest edition of Breakthough Technology Alert newletter
Breakthrough Technology Alert writer Ray Blanco features ISCO in his latest newsletter. I've copied a little of the text below (with the permission of the author)
--------------------------------------------------------------------------------------------
September 4, 2013
Important News: Stem Cell Specialists Moving Into Clinical Trials
Dear Breakthrough Technology Alert Reader,
ISCO Enters Into Clinical Agreement
International Stem Cell Corp. (OTCBB: ISCO) is going to be entering clinical trials soon. The company is developing its unique, ethical human parthenogenetic neural stem cell (hPNSC) technology into a treatment for Parkinson's disease................
You'll have to login here to read the whole post breakthroughtechnologyalert.agorafinancial.com
Subscribe to:
Posts (Atom)